Nexvet Biopharma plc
DelistedCIK 1618561fmd_1CW4B6NY9Q8TNW4EQWYES9FH5AManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2012 to Mar 31, 2017, 16 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | – |
| Research and development | 3 | 6 | 10 | 15 |
| Total operating expenses | 5 | 10 | 20 | 22 |
| Operating income | (4) | (10) | (20) | (22) |
| Interest and investment income | 0 | 0 | 0 | 0 |
| Income tax expense | – | – | 0 | 0 |
| Net income | (3) | (7) | (12) | (19) |